Legend Biotech

What would you say to someone who’s just been diagnosed? What can you share to remind them we are #MoreThanMyeloma? Spread hope. Share with us below. Thank you to @LegendBiotech @LegendUSMA for helping us spread myeloma awareness.

@IMFmyeloma @LegendUSMA You are #MoreThanMyeloma. ❤️

#MultipleMyeloma impacts 200K+ people annually, yet many don't know it until diagnosis. 🩸 The @theMMRF goes further—leveraging data & next-gen therapies to ensure every patient gets the best care. Learn more: themmrf.org #MyelomaAwarenessMonth #BloodCancer

We’ll be on site @AdTherapiesConf 2026 next week. On March 18, Sarah Snykers and Jan Vandersmissen speak at 11:10 on scaling global CAR-T manufacturing. Sarah also joins the 1:35 panel on decentralised vs centralised cell therapy manufacturing. Agenda: terrapinn.com/congress/advan…

@IMFmyeloma @LegendUSMA Thank you @IMFMyeloma, we’re honored to stand with the #MultipleMyeloma community!

Who made you feel like you were #MoreThanMyeloma? Tag them below to thank them. ❤️#MyelomaActionMonth Special thanks to @LegendBiotech and @LegendUSMA for helping us amplify myeloma voices.

#LegendNews: Today, we shared our Q4 and full-year 2025 financial results. Our growth was driven by the global expansion of our CAR-T program, reaching a major milestone in patient care, treating more than 10,000 patients worldwide. Read more:  investors.legendbiotech.com/news-releases/… $LEGN

Innovations in #MultipleMyeloma have nearly doubled life expectancy for some. We’re proud to deliver breakthrough therapies and grateful for the power of community organizations like @HealthTree. Together, we're building a stronger community 🤝 🔍 healthtree.org

We stand united this #IWD2026, recognizing the women whose leadership drives progress at Legend and across science and healthcare. Proud to work with our #LEGENDary team and the global scientific community to transform the future of medicine. 🌎🧬 #InternationalWomensDay

March is #MyelomaActionMonth, a reminder of the incredible progress reshaping the future of #MultipleMyeloma care. Organizations like @IMFMyeloma support the community through education, advocacy, and research. Learn more: myelomaactionmonth.org #MoreThanMyeloma #CellTherapy

@IMFmyeloma @LegendUSMA Thank you @IMFMyeloma for the important work you do to support and connect the #Myeloma community!

Myeloma is the 2nd most common blood cancer worldwide, but we are more than myeloma. Share what makes you #MoreThanMyeloma below! We thank Legend Biotech for helping us spread the facts. @LegendBiotech @LegendUSMA

What a week! Our Field Excellence Meeting brought the #LEGENDary team together—big energy, shared mission, and total alignment as one team: #PatientsFirst We left energized and ready to accelerate. The goal is clear: getting our #CellTherapy to more patients who need it most.

4 years since FDA approval and more than 10,000 patients treated, our #CART #CellTherapy reflects the power of innovation and collaboration in service of patients living with #MultipleMyeloma. We’re grateful to the patients and families who inspire this work. #HappyAnniversary

Behind every rare and complex disease is a patient waiting for progress – and they deserve our fullest commitment. In honor of #RareDiseaseDay tomorrow, we recognize the need for innovation, awareness, and advocacy for those affected by #MultipleMyeloma. #ShowYourStripes

#LegendNews: Legend will announce its Q4 and full-year 2025 #FinancialResults on Tuesday, March 10, at 8 a.m. ET. Join our webcast for an update on our progress: investors.legendbiotech.com/events-and-pre… $LEGN

Alan Bash, President of our CAR-T #CellTherapy, joined @onnewjersey to discuss how Legend & @JNJInnovMed are bringing hope to patients worldwide and redefining the future of #CancerCare. 📺 onnj.com/videos/legend-… #NJBiotech #PatientImpact #Innovation #CART #MulipleMyeloma

In a new @GoHealio article, two hematologists discuss a CAR-T #CellTherapy for relapsed or refractory #MultipleMyeloma, and the crucial role community oncologists play in referring their patients to certified CAR-T treatment centers. healio.com/advertorial/20… #Sponsored

Today, we celebrate the remarkable women driving scientific progress at Legend and support the next generation of innovators by fostering curiosity, inclusion, and opportunity for future women in #Science. #InternationalDayOfWomenAndGirlsInScience

Our time at #Tandem26 highlighted the transformative progress in #MultipleMyeloma landscape treatment and the need to advance evidence-based through clinical research and real-world insights. Ongoing scientific exchange with the #hematology community remains essential.

Our VP & Head of Early-Stage Drug Dev, Dong Geng, will participate in a panel on in vivo cell therapy Feb. 11 @ 1:20 p.m. at #IO360Summit. 📍 Track 2: Cell Therapy Plenary 🎤 In Vivo Cell Therapy: Rewriting the Rules of Cell-Based Treatment io360summit.com

At the #Tandem26 of @ASTCT and @CIBMTR, we’re sharing data that reinforces growing evidence which supports earlier use of our #CART #CellTherapy in #MultipleMyeloma. 📷 Read more: investors.legendbiotech.com/news-releases/…